Background
==========

Internal biliary fistulas represent only 2% of all biliary diseases \[[@b1-amjcaserep-20-398]\]. The most commonly reported types of fistula in order of frequency are: cholecystoduodenal, choledochoduodenal, cholecystocolonic, and cholecystogastric \[[@b1-amjcaserep-20-398],[@b2-amjcaserep-20-398]\]. These abnormal communications are usually related to biliary lithiasis \[[@b3-amjcaserep-20-398]\]. Choledochoduodenal fistula accounts for 5--25% of all internal biliary fistulas \[[@b4-amjcaserep-20-398]\]. Mostly duodeno-biliary fistula is caused by gall stones and subsequent inflammation of the bile duct; however, other causes, including duodenal ulcer, are possible \[[@b5-amjcaserep-20-398]\]. Rarely, an entero-biliary fistula can be attributed to a benign ulcer \[[@b6-amjcaserep-20-398]\], while giant peptic ulcers may perforate into the common bile duct \[[@b7-amjcaserep-20-398]\]. Notably, duodenal ulcer *per se* can cause fistula to other organs such as duodeno-pleural \[[@b8-amjcaserep-20-398]\], duodeno-portal \[[@b9-amjcaserep-20-398]\], or duodeno-ureteric fistula \[[@b10-amjcaserep-20-398]\]. Being a rare complication of peptic ulcer disease \[[@b11-amjcaserep-20-398]\], its diagnosis and management remains challenging. However, with the recent advances in hepato-biliary imaging techniques, suspecting this entity has become more plausible \[[@b12-amjcaserep-20-398]\], and thanks to these available endoscopic approaches, confirming the presence of choledochoduodenal fistula has become attainable in most cases \[[@b12-amjcaserep-20-398]\]. Here we report a case of choledochoduodenal fistula, which was ulcerogenic in origin and had a challenging diagnosis.

Case Report
===========

We present a case of a 29-year-old Ethiopian female, who had recurrent episodes of abdominal pain, and who presented to the Emergency Department complaining of severe epigastric pain. Her pain had been increasing in intensity for the past couple of days, and was associated with nausea and vomiting. Upon presentation, the patient was febrile and icteric. Abdominal examination revealed localized epigastric tenderness. Initial blood workup revealed leukocytosis, elevated C-reactive protein (CRP) and disturbed liver function tests as shown in [Table 1](#t1-amjcaserep-20-398){ref-type="table"}.

Abdominal ultrasound showed a distended gallbladder containing micro-lithiasis with dilatation of the intra and extra-hepatic bile ducts. Moreover, magnetic resonance cholangiopancreatography showed diffuse dilatation of intra and extra-hepatic bile ducts in the absence of stones or obstacles along with multiple hypointense images at the level of the intra-hepatic bile ducts, consistent with aerobilia as shown in [Figure 1](#f1-amjcaserep-20-398){ref-type="fig"}.

An attempt to do endoscopic retrograde cholangiopancreatography failed because the duodenum could not be bypassed due to the inflammatory process in the pyloric region as shown in [Figure 2](#f2-amjcaserep-20-398){ref-type="fig"}.

The examination was completed by an upper gastro-intestinal series with gastrografin swallow for better assessment of the pyloric stenosis. The examination revealed an extravasation of the contrast from the base of the duodenum at around 7 mm ulcer to the hepato-biliary tree along with a completely deformed duodenal bulb as shown in [Figure 3](#f3-amjcaserep-20-398){ref-type="fig"}.

The patient was diagnosed as having cholangitis secondary to a choledochoduodenal fistula. Broad spectrum antibiotic therapy was started. The patient underwent a laparotomy and a choledochoduodenal fistula was confirmed. We decided to do a cholecystectomy, a gastro-jejunostomy, and a hepaticojejunostomy. She recovered well, and was discharged home with an uneventful post-operative period.

Discussion
==========

Concerning diagnostic workup, bilio-enteric fistula is usually silent and found incidentally on gastrointestinal imaging \[[@b13-amjcaserep-20-398]\]. However, if present, the most common symptoms are those of cholangitis, including right upper quadrant pain, fever, and jaundice \[[@b14-amjcaserep-20-398]\]; which was similar to symptoms found in our patient. It could also be associated with gastrointestinal bleeding as a complication of peptic ulcer disease \[[@b15-amjcaserep-20-398]\]. Although pneumobilia can be helpful in diagnosis, it is not specific and found in only 14% to 22% of cases \[[@b16-amjcaserep-20-398]\]. The presence of contrast material in the biliary tree after a barium-swallow-study, in a patient suspected to have peptic ulcer disease, is highly suggestive of entero-biliary fistula \[[@b17-amjcaserep-20-398]\]. Notably, these 2 latter radiographic features may be present after endoscopic papillotomy or after surgical biliary-enteric anastomosis. However, in the absence of such events, these findings are diagnostic of entero-biliary fistula \[[@b18-amjcaserep-20-398]\].

Concerning management and despite the increased rate of choledochoduodenal fistula diagnosis, there is still no consensus regarding the treatment and management strategies. Some studies dictate that the mere presence of fistula is not an absolute indication for surgery \[[@b19-amjcaserep-20-398]\] and management depends on the type and cause of fistula \[[@b20-amjcaserep-20-398]\]. However, percutaneous or endoscopic interventions may be a treatment option \[[@b21-amjcaserep-20-398]--[@b25-amjcaserep-20-398]\]. However, when symptoms are poorly controlled as in a biliary obstruction or hemorrhage, surgical options prevail \[[@b21-amjcaserep-20-398],[@b25-amjcaserep-20-398]\]. In our patient case, our patient was treated medically for cholangitis, but she did not improve, thus she underwent a double derivation and had an uneventful postoperative course. However, some reports endorse surgical management, avoiding the risk of cholangiocarcinoma \[[@b26-amjcaserep-20-398],[@b27-amjcaserep-20-398]\]. Moreover, a high index of suspicion is required to prevent long term complications such as acute cholangitis or small bowel obstruction \[[@b28-amjcaserep-20-398]\], conditions in which mortality is high and surgical management is inevitable.

Study limitations
-----------------

This study aimed to pinpoint a rare complication of a relatively common disease, however, it provides little evidence concerning the treatment plan. It is a case report that needs to be endorsed by other studies higher in quality to allow us to know more about managing this condition.

Conclusions
===========

Choledochoduodenal fistula is a rare complication of duodenal ulcer. Patients may present with non-specific clinical symptoms, which makes the diagnosis difficult. Pneumobilia and the presence of contrast in the biliary tree should always alert the clinician to the possibility of choledochoduodenal fistula. Surgery should be considered for refractory cases. This case report is a reminder of a rare complication for a relatively common disease: peptic ulcer disease.
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![Magnetic resonance cholangiopancreatography showing diffuse dilatation of intra and extra-hepatic bile ducts in the presence of aerobilia.](amjcaserep-20-398-g001){#f1-amjcaserep-20-398}

![Endoscopic retrograde cholangiopancreatography showing pyloric region being inflamed and ulcerated.](amjcaserep-20-398-g002){#f2-amjcaserep-20-398}

![Gastrografin swallow showing fistula between the duodenum and the biliary tree.](amjcaserep-20-398-g003){#f3-amjcaserep-20-398}

###### 

An overview of the patient's initial laboratory workup.

  **Results**                     **Normal range**
  ------------------------------- ------------------------
  Hematocrit: 38                  36--48%
  Hemoglobin: 12.9                12--16 g%
  Red blood cells: 4.58           4--6 million/mm^3^
  White blood cells: 1 1500^\*^   4000--10 000/mm^3^
    Neutrophils: 90^\*^           40--80%
    Lymphocytes: 8^\*^            20--40%
  Platelets: 250000               150 000--300 000/mm^3^
  C-reactive protein: 52^\*^      0--5 mg/L
  Albumin: 2.5^\*^                3.4--5 g%
  Bilirubin                       
    Direct: 2.8^\*^               0--0.2 mg%
    Total: 4.9^\*^                0--1 mg%
  Alkaline phosphatase: 123^\*^   37--98 U/L
  ALT: 436^\*^                    \<65 U/L
  AST: 335^\*^                    \<37 U/L
  GGT: 346^\*^                    5--55 U/L
  Amylase: 162^\*^                25--115 U/L
  Lipase: 106                     73--393 U/L
  INR: 1.68^\*^                   1
  PTT: 40^\*^                     30

GGT -- gamma-glutamyltransferase; ALT -- alanine transaminase; AST -- aspartate transaminase; INR -- international normalized ratio; PTT -- partial thromboplastin time.
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